Dr. Frist became a member of the Teladoc Health board of directors in September 2014.
Since 2007, Dr. Frist has served as a special partner in Cressey & Company, a private investment firm focused exclusively on investing in and building leading healthcare businesses. He is chairman of the Cressey Distinguished Executives Council. Dr. Frist is also a partner at Frist Cressey Ventures, a venture capital firm specializing in healthcare investments. As a U.S. Senator, Dr. Frist represented Tennessee for 12 years, where he served on both the Finance and Health, Education, Labor and Pensions (HELP) committees responsible for writing all health legislation. He served as U.S. Senate majority leader from 2003 to 2007.
Prior to the Senate, Dr. Frist spent 20 years in clinical medicine, completing surgical training at Harvard’s Massachusetts General Hospital and Stanford, and he subsequently founded the Vanderbilt Transplant Center. Dr. Frist serves as an adjunct professor of cardiac surgery at Vanderbilt University. His previous board service includes Princeton University and the Smithsonian Institution.
Dr. Frist currently serves as a director of Select Medical. In addition, he serves on the boards of Aegis Sciences Corporation, MDSave and Devoted Health. He previously served as a director of SmileDirectClub, Accolade, GS Acquisition Holdings Corp. II, AECOM, URS Corporation, and Third National Bank.
His current board service also includes the Robert Wood Johnson Foundation, The Nature Conservancy, NashvilleHealth and Tennessee’s State Collaborative on Education (SCORE). Dr. Frist earned his B.A. from Princeton University and MD from Harvard Medical School.
What is William H. Frist's net worth?
The estimated net worth of William H. Frist is at least $578,169.00 as of May 12th, 2021. Mr. Frist owns 64,241 shares of Teladoc Health stock worth more than $578,169 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Frist may own. Learn More about William H. Frist's net worth.
How do I contact William H. Frist?
Has William H. Frist been buying or selling shares of Teladoc Health?
William H. Frist has not been actively trading shares of Teladoc Health within the last three months. Most recently, William H. Frist sold 740 shares of the business's stock in a transaction on Friday, September 25th. The shares were sold at an average price of $208.50, for a transaction totalling $154,290.00. Following the completion of the sale, the director now directly owns 6,158 shares of the company's stock, valued at $1,283,943. Learn More on William H. Frist's trading history.
Who are Teladoc Health's active insiders?
Teladoc Health's insider roster includes Michelle Bucaria (Insider), Karen Daniel (Director), Sandra Fenwick (Director), William Frist (Director), Arnnon Geshuri (Insider), Jason Gorevic (CEO), Claus Jensen (Insider), Laizer Kornwasser (President, Enterprise Growth and Global Markets), Lewis Levy (Insider), Mala Murthy (CFO), Richard Napolitano (CAO), Kenneth Paulus (Director), Vidya Raman-Tangella (Insider), David Shedlarz (Director), David Sides (COO), Hemant Taneja (Director), Daniel Trencher (SVP), Andrew Turitz (SVP), Adam Vandervoort (Insider), Stephany Verstraete (CMO), Yulun Wang (Insider), and Michael Waters (COO). Learn More on Teladoc Health's active insiders.
Are insiders buying or selling shares of Teladoc Health?
During the last year, Teladoc Health insiders bought shares 2 times. They purchased a total of 11,000 shares worth more than $83,750.00. During the last year, insiders at the health services provider sold shares 38 times. They sold a total of 266,139 shares worth more than $3,768,176.90. The most recent insider tranaction occured on September, 12th when Director Thomas Mckinley bought 4,000 shares worth more than $30,760.00. Insiders at Teladoc Health own 1.0% of the company.
Learn More about insider trades at Teladoc Health. Information on this page was last updated on 9/12/2024.
